Researchers Analyzed 1,000 People Over 16 Years. They Found an Unexpected Alzheimer’s-Linked Pattern
A study from the University of Oslo in Norway found that MRI scans may be able to identify a key brain change earlier than ...
Smithsonian Magazine on MSN
MRI scans might reveal signs of Alzheimer's disease seven years before a telltale marker appears in the brain
Alzheimer’s disease is a devastating neurodegenerative disorder and the most common form of dementia. It’s marked by the ...
MRI scans can detect signs of the disease years earlier than PET scans, a recent study published in ‘Nature Neuroscience’ ...
FOX 10 Phoenix on MSN
Arizona researchers lead study on breakthrough Alzheimer's disease blood test
A collaborative study led by researchers in Arizona found that a new blood test improves early detection of Alzheimer's ...
The Healthy @Reader's Digest on MSN
I’m a Geriatrics Doctor—Here Are the 9 Things I Wish More People Understood About Alzheimer’s
An expert doctor explains the difference between Alzheimer's versus dementia, how you can impact your long-term brain health ...
Alzheimer’s disease slowly damages brain cells and is the most common cause of dementia. It can lead to worsening memory, ...
Verywell Health on MSN
Current treatment options for Alzheimer’s disease
Medically reviewed by Smita Patel, DO Key Takeaways Anti-amyloid medications taken in early-stage Alzheimer’s may slow ...
For more than three decades, the dominant hypothesis in Alzheimer’s disease research has rested on a single idea: that the ...
The latest approvals expand the population of people who could be tested for the memory disorder—but experts warn the tests aren't for everyone.
[BrainBay] Dopamine at the gateway of memory was found to be reduced in an Alzheimer's disease model
A joint study by Tohoku University and the University of California, Irvine, was published in Nature Neuroscience on April 23 ...
Alzheimer’s disease slowly damages memory, thinking and the ability to manage everyday life. One major sign of the disease is ...
The pathology of Alzheimer's disease has an inflammatory component that is characterized by upregulation of proinflammatory cytokines, particularly in response to amyloid-β (Aβ). Using the APPPS1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results